CIK 0001635088
- Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- Operating
- EIN
- 981173944
- Phone
- +44 12955950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $70,369,463
- in 12 filings, $45.5M under 10b5-1 plans
Net −$70,369,463. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-10 | Oren Ilan Director | Grant or award | +16,406 | 99,040 | ||
| 2024-09-10 | Oren Ilan Director | Grant or award · Stock Option (Right to Buy) | +27,894 | 27,894 | ||
| 2024-09-10 | MOMTAZEE JAMES C Director | Grant or award | +16,406 | 95,490 | ||
| 2024-09-10 | MOMTAZEE JAMES C Director | Grant or award · Stock Option (Right to Buy) | +27,894 | 27,894 | ||
| 2024-08-28 | Pulik Richard CFO | Shares withheld for taxes 10b5-1 | −2,341 | $12.00 | $28K | 285,752 |
| 2024-08-20 | Kumar Rakhi Chief Accounting Officer | Shares withheld for taxes 10b5-1 | −958 | $11.48 | $11K | 212,409 |
| 2024-08-20 | Venker Eric President & COO | Shares withheld for taxes 10b5-1 | −10,947 | $11.48 | $126K | 639,360 |
| 2024-08-20 | Gline Matthew CEO | Shares withheld for taxes 10b5-1 | −10,947 | $11.48 | $126K | 18,314,745 |
| 2024-07-28 | Pulik Richard CFO | Shares withheld for taxes 10b5-1 | −2,341 | $10.80 | $25K | 288,093 |
| 2024-07-26 | Gline Matthew CEO | Grant or award | +2,754,821 | 3,875,692 | ||
| 2024-07-26 | Gline Matthew CEO | Grant or award | +14,450,000 | 18,325,692 | ||
| 2024-07-26 | Sukhatme Mayukh Pres&Chief Investment Officer | Grant or award | +1,836,547 | 5,488,532 | ||
| 2024-07-26 | Sukhatme Mayukh Pres&Chief Investment Officer | Grant or award | +17,000,000 | 22,488,532 | ||
| 2024-07-26 | Venker Eric President & COO | Grant or award | +204,000 | 650,307 | ||
| 2024-07-26 | Venker Eric President & COO | Grant or award · Stock Option (Right to Buy) | +409,000 | 409,000 | ||
| 2024-07-23 | Oren Ilan Director | Grant or award | +2,440 | 82,849 | ||
| 2024-07-23 | Oren Ilan Director | Shares withheld for taxes | −215 | $11.01 | $2K | 82,634 |
| 2024-07-23 | MOMTAZEE JAMES C Director | Grant or award | +1,555 | 79,091 | ||
| 2024-07-23 | Epperly Melissa B, Director | Grant or award | +1,702 | 24,263 | ||
| 2024-07-20 | Gline Matthew CEO | Shares withheld for taxes 10b5-1 | −10,945 | $11.00 | $120K | 1,120,871 |
Page 30 of 38 · 748 trades